Pristinamycin in the treatment of MSSA bone and joint infection

Antimicrobial Activity against Intraosteoblastic Staphylococcus aureus

(2015) Florent Valour et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation

(2015) F. Valour et al.   CLINICAL MICROBIOLOGY AND INFECTION

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

(2015) Steven Y. C. Tong et al.   CLINICAL MICROBIOLOGY REVIEWS

Pristinamycin: old drug, new tricks?

(2014) E. C. Cooper et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial-Related Severe Adverse Events during Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus aureus

(2013) Florent Valour et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Streptogramins – Two are better than one!

(2013) Yvonne Mast et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials

(2012) Carla Renata Arciola et al.   BIOMATERIALS

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2012) D. R. Osmon et al.   CLINICAL INFECTIOUS DISEASES

2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections

(2012) B. A. Lipsky et al.   CLINICAL INFECTIOUS DISEASES

Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital

(2010) A. B. Reid et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penetration of Antibacterials into Bone

(2009) Cornelia B. Landersdorfer et al.   CLINICAL PHARMACOKINETICS

Recommandations de pratique clinique. Infections osteo-articulaires sur materiel (prothese, implant, osteo-synthese)

(2009)   MEDECINE ET MALADIES INFECTIEUSES

Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes

(2008) Marilyn C. Roberts   FEMS MICROBIOLOGY LETTERS

Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection

(2008) N. Ruparelia et al.   JOURNAL OF INFECTION